// App-Quantinova.ai

427 2016 BCVS : Tissue Inhibitor of Matrix Metalloproteinase-3 (TIMP3) Provides Beneficial Effects Post-MI by Promoting Angiogenesis

Researchers

Presenter

  • Pu Zhang

Principal Investigators

  • Ratnadeep Basu

  • Abul Azad

  • Maikel Farhan

  • Xiuhua Wang

  • Allan Murray

  • Zamaneh Kassiri

Medical Centers

  • Univ. of Alberta, Edmonton, Alberta, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

Biomarkers

  • Cluster of Differentiation 31

  • Kinase Insert Domain Receptor

Drug/Treatment

  • TIMP-3 secretion inducer

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved